Investigation of circulatory and tissue ACE activity during development of lead-induced hypertension

被引:33
作者
Sharifi, AM
Darabi, R
Akbarloo, N
Larijani, B
Khoshbaten, A
机构
[1] Iran Univ Med Sci, Sch Med, Dept Pharmacol & Cellular, Tehran, Iran
[2] Iran Univ Med Sci, Sch Med, Mol Res Ctr, Tehran, Iran
[3] Univ Tehran, Endocrinol & Metab Res Ctr, Tehran, Iran
[4] Baghyatollah Univ Med Sci, Dept Physiol & Biophys, Tehran, Iran
关键词
lead; hypertension; ACE activity;
D O I
10.1016/j.toxlet.2004.04.013
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Prolonged exposure to low levels of lead causes systemic hypertension. Several mechanisms have been proposed to explain lead-induced hypertension. Recently, the etiological role of the renin-angiotensin system (RAS) has been investigated in this context. This study assessed the alterations of circulatory and tissue angiotensin converting enzyme (ACE) activity during development of lead induced hypertension. Male rats were divided to two main groups: lead-treated animals which received lead acetate. 100 ppm, in drinking water for 2, 4, 6, and 8 weeks and a control group given distilled water. The ACE activity in serum and tissues was analyzed by HPLC. The blood pressure gradually increased in correlation with lead exposure with time. The study also revealed significant elevation of local and serum ACE activity in the early phase of lead treatment; however, chronic lead exposure suppressed ACE activity in serum and tissues. These results emphasize the etiological role of ACE activity in the early phase of lead-induced hypertension. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 30 条
[1]   NEUROHUMORAL BLOOD-PRESSURE REGULATION IN LEAD-EXPOSURE [J].
BOSCOLO, P ;
CARMIGNANI, M .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1988, 78 :101-106
[2]   LEAD-EXPOSURE AND CHANGES IN THE RENIN-ANGIOTENSIN ALDOSTERONE SYSTEM IN MAN [J].
CAMPBELL, BC ;
MEREDITH, PA ;
SCOTT, JJC .
TOXICOLOGY LETTERS, 1985, 25 (01) :25-32
[3]   Kininergic system and arterial hypertension following chronic exposure to inorganic lead [J].
Carmignani, M ;
Boscolo, P ;
Poma, A ;
Volpe, AR .
IMMUNOPHARMACOLOGY, 1999, 44 (1-2) :105-110
[4]   Reduced vascular beta-adrenergic receptors and catecholamine response in rats with lead induced hypertension [J].
Chang, HR ;
Chen, SS ;
Tsao, DA ;
Cheng, JT ;
Ho, CK ;
Yu, HS .
ARCHIVES OF TOXICOLOGY, 1997, 71 (12) :778-781
[5]  
Danser AHJ, 1996, MOL CELL BIOCHEM, V157, P211
[6]   Increase by NO synthase inhibitor of lead-induced release of N-acetyl-β-D-glucosaminidase from perfused rat kidney [J].
Dehpour, AR ;
Essalat, M ;
Ala, S ;
Ghazi-Khansari, M ;
Ghafourifar, P .
TOXICOLOGY, 1999, 132 (2-3) :119-125
[7]  
DZAU VJ, 1988, CIRCULATION S1, V77, P14
[8]  
DZAU VJ, 1986, HEART CARDIOVASCULAR, P1631
[9]   Lead-induced hypertension - Interplay of nitric oxide and reactive oxygen species [J].
Gonick, HC ;
Ding, YX ;
Bondy, SC ;
Ni, ZM ;
Vaziri, ND .
HYPERTENSION, 1997, 30 (06) :1487-1492
[10]   Can antioxidants be beneficial in the treatment of lead poisoning? [J].
Gurer, H ;
Ercal, N .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (10) :927-945